arrow
Back
C

Christopher J. Lord

The Institute of Cancer Research

98H-index
704Paper Count
4.5WCitation Count
Published Papers 231
Publication Date
The anion channel GPR89 is a tumor-specific dependency in breast cancer
err2026-08-24
err0
errOAAI
errRiccardo Ferro; Alexandra Carroll; Ana M. Mendes-Pereira; Virinder Reen; George Vlachogiannis; Rebeca Uceda-Castro; Dragomir Krastev; Valeria Amodeo; Stephen Pettitt; Nadja D’Uonno; Ioanna Mavrommati; Blanca Navarro; Luke Hitchen; Jennifer Trendell; Ana Stojiljkovic; Cynthia Prince; Narinder Janghra; Ioannis Roxanis; Patrycja Gazinska; Daniel Larcombe-Young; Rebecca Marlow; Stefano Annunziato; Jos Jonkers; Tejashree Rajaram Kanitkar; Amadeus Xu; Nirmesh Patel; Nalan Liv; John Alexander; Jelmar Quist; Mercedes Pardo; Theodoros I. Roumeliotis; Jyoti S. Choudhary; Daniel Weekes; Pierfrancesco Marra; Joanna I. Loizou; Rachael Natrajan; Anita Grigoriadis; Mallur Srivatsan Madhusudhan; Syed Haider; Christopher J. Lord; Andrew Tutt
errShare
errSave
Nucleophagy removes cytotoxic trapped PARP1
err2026-06-02
err0
errOAAI
errGwendoline Hoslett; Sara Tribble; Pauline Lascaux; Stelios Koukouravas; Ignacio Torrecilla; Wei Song; Cynthia X. Hou; Junyi Li; Martín González-Fernández; Giuliana De Gregoriis; Rebecca A. Dagg; Darragh O’Brien; Andrea Pierangelini; Thibaud Martial; Alvin Wei Tian Ng; Nuno Raimundo; Ira Milosevic; Raimundo Freire; Yuliang Li; Sven Rottenberg; Dragomir B. Krastev; Christopher J. Lord; Madalena Tarsounas; Kristijan Ramadan
errShare
errSave
Two decades of PARP inhibitor synthetic lethality in cancer
errNature
IF48.5
err2026-05-06
err0
PREAI
errChristopher J. Lord; Andrew N. J. Tutt; Alan Ashworth
errShare
errSave
Targeting non-canonical NF-κB signalling in CYLD cutaneous syndrome by selective inhibition of IκB kinase alpha
err2026-03-04
err0
errOAAI
errKirsty Hodgson; Joseph Inns; Gary Reynolds; Emily Stephenson; Andrew Paul; Naomi Sinclair; Giacomo Berretta; Christopher Lawson; Andrew Michael Frey; Iglika Ivanova; Eva Adam; Christopher J Lord; Simon Cockell; Jonathan Coxhead; Nikoletta Nagy; David Adams; Marta Szell; Matthias Trost; Muzlifah Haniffa; Simon P Mackay; Neil Perkins; Neil Rajan; null
errShare
errSave
NASP modulates histone turnover to drive PARP inhibitor resistance
errNature
IF48.5
err2025-08-13
err0
PREAI
errSarah C. Moser; Anna Khalizieva; Josef Roehsner; Elisabeth Pottendorfer; Milo L. Kaptein; Giulia Ricci; Vivek Bhardwaj; Onno B. Bleijerveld; Liesbeth Hoekman; Ingrid van der Heijden; Simone di Sanzo; Alexander Fish; Aleksandra Chikunova; Judith H. I. Haarhuis; Roel Oldenkamp; Luisa Robbez-Masson; Justin Sprengers; Daniel J. Vis; Lodewyk F. A. Wessels; Marieke van de Ven; Stephen J. Pettitt; Andrew N. J. Tutt; Christopher J. Lord; Benjamin D. Rowland; Moritz Völker-Albert; Francesca Mattiroli; Thijn R. Brummelkamp; Abdelghani Mazouzi; Jos Jonkers
errShare
errSave
Tumor control and immune activation through palliative irradiation and ATR inhibition, PATRIOT Part C: a phase Ib trial
err2025-08-01
err0
errOAAI
errMagnus T. Dillon; Emmanuel C. Patin; Kabir Mohammed; Jeane Guevara; Simon A. Smith; Emma Dean; Heba Soliman; Pablo Nenclares; Motoko Ryugenji; Davina Northcote; Neel Shah; Lorna Grove; Christopher J. Lord; Stephen Pettit; Matt Tall; Karen E. Swales; Udai Banerji; Alan A. Melcher; Mark Saunders; Martin D. Forster; Kevin J. Harrington
errShare
errSave
Clinical challenges and proposed solutions for patients with invasive lobular breast cancer
err2025-07-21
err0
errOAAI
errK. Van Baelen; E. Sawyer; J. Van Cauwenberge; P. Aftimos; M.F. Covington; M. Maetens; G. Zels; C. Brisken; L. Djerroudi; R. Dresen; A. Fitzpatrick; R.L. Flaherty; G. Floris; S. Freeney; A.B. Hanker; D. Honey; C.M. Isacke; R.C. Jankowitz; R. Jeselsohn; T. Koorman; C. Kuhl; S. Linn; C.J. Lord; C. Malhaire; J. Mouabbi; R. Mukhtar; G. Nader-Marta; R. Natrajan; P. Neven; S. Oesterreich; J.L. Sandoval; S.J. Schnitt; E. Senkus; C. Turner; V. Vandecaveye; H. Wildiers; A. Vincent-Salomon; P.W.B. Derksen; C. Desmedt
errShare
errSave
Author Correction: Palbociclib and dsRNA sensor co-operate to enhance anti-cancer effects through ER stress and modulation of immune evasion
err2025-07-15
err0
errOAAI
errVictoria Roulstone; Joan Kyula-Currie; James Wright; Emmanuel C. Patin; Isaac Dean; Lu Yu; Aida Barreiro-Alonso; Miriam Melake; Jyoti Choudhary; Richard Elliott; Christopher J. Lord; David Mansfield; Nik Matthews; Ritika Chauhan; Victoria Jennings; Charleen Chan Wah Hak; Holly Baldock; Francesca Butera; Elizabeth Appleton; Pablo Nenclares; Malin Pedersen; Shane Foo; Amarin Wongariyapak; Antonio Rullan; Tencho Tenev; Pascal Meier; Richard Vile; Hardev Pandha; Alan Melcher; Martin McLaughlin; Kevin J. Harrington
errShare
errSave
The PARP inhibitor talazoparib synergizes with reovirus to induce cancer killing and tumour control in vivo in mouse models
err2025-07-08
err0
errOAAI
errJoan Kyula-Currie; Victoria Roulstone; James Wright; Francesca Butera; Arnaud Legrand; Richard Elliott; Martin McLaughlin; Galabina Bozhanova; Dragomir Krastev; Stephen Pettitt; Tencho Tenev; Magnus Dillon; Shane Foo; Emmanuel C. Patin; Victoria Jennings; Charleen Chan Wah Hak; Elizabeth Appleton; Amarin Wongariyapak; Malin Pedersen; Antonio Rullan; Jyoti Choudhary; Chris Bakal; Pascal Meier; Christopher J. Lord; Alan Melcher; Kevin J. Harrington
errShare
errSave
Unraveling complexity and leveraging opportunities in uncommon breast cancer subtypes
err2025-01-24
err0
errOAAI
errPareja, Fresia; Bhargava, Rohit; Borges, Virginia F.; Brogi, Edi; Canas Marques, Rita; Cardoso, Fatima; Desmedt, Christine; Harigopal, Malini; Lakhani, Sunil R.; Lee, Adrian; Leone, Jose Pablo; Linden, Hannah; Lord, Christopher J.; Marchio, Caterina; Merajver, Sofia D.; Rakha, Emad; Reis-Filho, Jorge S.; Richardson, Andrea; Sawyer, Elinor; Schedin, Pepper; Schwartz, Christopher J.; Tutt, Andrew; Ueno, Naoto T.; Vincent-Salomon, Anne; Weigelt, Britta; Wen, Y. Hannah; Schnitt, Stuart J.; Oesterreich, Steffi
errShare
errSave
Inhibition of GPX4 enhances CDK4/6 inhibitor and endocrine therapy activity in breast cancer
err2024-11-05
err0
errOAAI
errHerrera-Abreu, M. T.; Guan, J.; Khalid, U.; Ning, J.; Costa, M. R.; Chan, J.; Li, Q.; Fortin, J-p.; Wong, W. R.; Perampalam, P.; Biton, A.; Sandoval, W.; Vijay, J.; Hafner, M.; Cutts, R.; Wilson, G.; Frankum, J.; Roumeliotis, T. I.; Alexander, J.; Hickman, O.; Brough, R.; Haider, S.; Choudhary, J.; Lord, C. J.; Swain, A.; Metcalfe, C.; Turner, N. C.
errShare
errSave
CDK12 loss drives prostate cancer progression, transcription-replication conflicts, and synthetic lethality with paralog CDK13
err2024-10-01
err0
errOAAI
errTien, Jean Ching-Yi; Luo, Jie; Chang, Yu; Zhang, Yuping; Cheng, Yunhui; Wang, Xiaoju; Yang, Jianzhang; Mannan, Rahul; Mahapatra, Somnath; Shah, Palak; Wang, Xiao-Ming; Todd, Abigail J.; Eyunni, Sanjana; Cheng, Caleb; Rebernick, Ryan J.; Xiao, Lanbo; Bao, Yi; Neiswender, James; Brough, Rachel; Pettitt, Stephen J.; Cao, Xuhong; Miner, Stephanie J.; Zhou, Licheng; Wu, Yi-Mi; Labanca, Estefania; Wang, Yuzhuo; Parolia, Abhijit; Cieslik, Marcin; Robinson, Dan R.; Wang, Zhen; Feng, Felix Y.; Chou, Jonathan; Lord, Christopher J.; Ding, Ke; Chinnaiyan, Arul M.
errShare
errSave
CDK12 loss promotes prostate cancer development while exposing vulnerabilities to paralog-based synthetic lethality
err2024-06-10
err0
PREAI
errTien, Jean C.; Chang, Yu; Zhang, Yuping; Chou, Jonathan; Cheng, Yunhui; Wang, Xiaoju; Yang, Jianzhang; Mannan, Rahul; Shah, Palak; Wang, Xiao-Ming; Todd, Abbey; Eyunni, Sanjana; Cheng, Caleb; Cao, Xuhong; Bao, Yi; Neiswender, James; Brough, Rachel; Pettitt, Stephen; Labanca, Estefania; Wang, Yuzhuo; Cieslik, Marcin; Lord, Christopher J.; Ding, Ke; Chinnaiyan, Arul M.
errShare
errSave
RNASEH2B loss and PARP inhibition in advanced prostate cancer
err2024-06-04
err0
errOAAI
errCarmichael, Juliet; Figueiredo, Ines; Gurel, Bora; Beije, Nick; Yuan, Wei; Rekowski, Jan; Seed, George; Carreira, Suzanne; Bertan, Claudia; de La Maza, Maria de Los Dolores Fenor; Chandran, Khobe; Neeb, Antje; Welti, Jon; Gallagher, Lewis; Bogdan, Denisa; Crespo, Mateus; Riisnaes, Ruth; Ferreira, Ana; Miranda, Susana; Lu, Jinqiu; Shen, Michael M.; Hall, Emma; Porta, Nuria; Westaby, Daniel; Guo, Christina; Grochot, Rafael; Lord, Christopher J.; Mateo, Joaquin; Sharp, Adam; de Bono, Johann
errShare
errSave
Functional assessment of RAD51 foci and replication fork dynamics in PARPi resistant BRCA1/2 mutated breast cancer
err2024-05-02
err0
PREAI
errHarvey-Jones, Elizabeth; Raghunandan, Maya; Robbez-Masson, Luisa; Alaguthurai, Thanussuyah; Llop-Guevara, Alba; Trendell, Jennifer; Rodriguez, Olga; Guzman, Marta; Weekes, Daniel; deRenty, Christelle; Knight, Eleanor; Marlow, Rebecca; Starling, Christopher; Liu, Ruifang; Ravindran, Nivedita; Roxanis, Ioannis; Lukashchuk, Natalia; Serra, Violeta; Pettitt, Stephen; Lord, Christopher; Tutt, Andrew N. J.
errShare
errSave
Inhibition of GPX4 enhances CDK4/6 inhibitor activity in breast cancer
err2024-05-02
err0
PREAI
errAbreu, Maria Teresa Herrera; Khalid, Uzma; Ning, Jian; Cutts, Rosalind; Wilson, Gemma; Lord, Christopher; Swain, Amanda; Turner, Nicholas
errShare
errSave
Pathway-based signatures predict patient outcome, chemotherapy benefit and synthetic lethal dependencies in invasive lobular breast cancer
err2024-04-10
err2
errOAAI
errAlexander, John; Schipper, Koen; Nash, Sarah; Brough, Rachel; Kemp, Harriet; Iacovacci, Jacopo; Isacke, Clare; Natrajan, Rachael; Sawyer, Elinor; Lord, Christopher J.; Haider, Syed
errShare
errSave
Longitudinal pro fi ling identi fi es co-occurring BRCA1/2 reversions, TP53BP1, RIF1 and PAXIP1 mutations in PARP inhibitor-resistant advanced breast cancer
err2024-04-01
err13
errOAAI
errHarvey-Jones, E.; Raghunandan, M.; Robbez-Masson, L.; Magraner-Pardo, L.; Alaguthurai, T.; Yablonovitch, A.; Yen, J.; Xiao, H.; Brough, R.; Frankum, J.; Song, F.; Yeung, J.; Savy, T.; Gulati, A.; Alexander, J.; Kemp, H.; Starling, C.; Konde, A.; Marlow, R.; Cheang, M.; Proszek, P.; Hubank, M.; Cai, M.; Trendell, J.; Lu, R.; Liccardo, R.; Ravindran, N.; Llop-Guevara, A.; Rodriguez, O.; Balmana, J.; Lukashchuk, N.; Dorschner, M.; Drusbosky, L.; Roxanis, I.; Serra, V.; Haider, S.; Pettitt, S. J.; Lord, C. J.; Tutt, A. N. J.
errShare
errSave
SF3B1 hotspot mutations confer sensitivity to PARP inhibition through a defective replication stress response
err2023-12-01
err0
PREAI
errBland, Philip; Saville, Harry; Wai, Patty T.; Curnow, Lucinda; Nieminuszczy, Jadwiga; Ravindran, Nivedita; Barker, Holly E.; Wright, James; Yu, Lu; Mavrommati, Ioanna; Peck, Barrie; Gazinska, Patrycja; Pemberton, Helen N.; Gulati, Aditi; Guppy, Naomi; Roxanis, Ioannis; Pratt, Guy; Oldreive, Ceri; Stankovic, Tatjana; Barlow, Samantha; Kalirai, Helen; Coupland, Sarah E.; Broderick, Ronan; Alsafadi, Samar; Houy, Alexandre; Stern, Marc-Henri; Pettit, Stephen; Choudhary, Jyoti S.; Haider, Syed; Niedzwiedz, Wojciech; Lord, Christopher J.; Natrajan, Rachael
errShare
errSave
Complex synthetic lethality in cancer
err2023-11-30
err7
PREAI
errRyan, Colm J.; Devakumar, Lovely Paul Solomon; Pettitt, Stephen J.; Lord, Christopher J.
errShare
errSave